Philadelphia, Pennsylvania, United States, April 2026 — Sonia Hardaway has stepped into the role of Vice President, People & Culture at Jazz Pharmaceuticals. In this position, she leads the enterprise People & Culture Center of Excellence, delivering integrated people strategies and experiences designed to drive organizational performance, strengthen leadership and culture, and enable employees and teams to succeed in advancing the company’s purpose-driven mission for patients and families. Her current role at Jazz Pharmaceuticals is reflected in the experience details provided.
Before taking on this role, Sonia Hardaway served as Head of Organizational and Talent Solutions at Jazz Pharmaceuticals. That role added further depth to her leadership profile within the company and positioned her strongly for this expanded people leadership mandate. Her move to Vice President, People & Culture reflects both her contribution to the organization and the trust placed in her ability to guide enterprise-wide people strategy.
Prior to joining Jazz Pharmaceuticals, she spent more than seven years with Cigna Healthcare, where she held major people leadership roles. Most recently, she served as HR Executive, US Commercial | AI Talent Readiness | Organizational Design | Change Management, leading the national talent strategy for Cigna’s $30 billion US Commercial business and a workforce of 4,000 employees. In that role, she drove organizational alignment, shaped a culture of belonging, supported leadership transition planning, advanced total rewards evolution, and led the development of a strategic workforce plan around AI and GenAI readiness. Earlier at Cigna, she also served as Global Head of Organizational Development | Enterprise Solutions | Performance Optimization | M&A, where she built the company’s first Center of Excellence for Organizational Development, supported major acquisition integration, and helped drive agile transformation across technology and business units.
A significant phase of Sonia Hardaway’s career was built at Bristol-Myers Squibb, where she spent more than sixteen years across a range of senior HR and talent leadership roles. She served as Chief Learning Officer | Leadership Development | Talent Management, where she helped modernize the company’s learning and development strategy, established an enterprise-wide center of excellence, launched leadership and succession programs, and introduced a digital learning platform for 25,000 employees. She also held roles including Strategic HR Business Partner, R&D | Talent Strategy | Organizational Development, Senior HR Business Partner, Global Medical, R&D | Talent Strategy | Transformation, and other earlier HR and organizational development positions. These experiences gave her broad expertise across leadership development, talent strategy, transformation, R&D HR partnership, and global organizational effectiveness.
Earlier in her professional journey, Sonia Hardaway was associated with CIGNA as Financial & Actuarial Leadership Program Director and previously as Human Resources Associate, HR Development Program in Philadelphia, Pennsylvania. These early assignments helped build the HR and leadership foundation that has supported her long-term progression into senior people leadership roles across major healthcare and biopharmaceutical organizations.
With leadership experience spanning Jazz Pharmaceuticals, Cigna Healthcare, Bristol-Myers Squibb, and CIGNA, Sonia Hardaway brings deep expertise across people strategy, organizational development, leadership capability, talent management, transformation, and culture building. Her appointment as Vice President, People & Culture is expected to support Jazz Pharmaceuticals as it continues to strengthen its workforce, leadership culture, and patient-centered mission.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. The company focuses on developing life-changing medicines for people with serious diseases, often where limited or no options exist, so they can live more fully. Founded in 2003 and headquartered in Dublin, Ireland, Jazz Pharmaceuticals has a significant corporate presence in Palo Alto, California, Philadelphia, Pennsylvania, and in London, Oxford, and Cambridge in England, with manufacturing facilities in Ireland, England, and Italy. The company emphasizes a collaborative culture shaped by values including integrity, collaboration, passion, innovation, and the pursuit of excellence.
